348 related articles for article (PubMed ID: 23169608)
1. Metabolism and pharmacokinetics of 3-n-butylphthalide (NBP) in humans: the role of cytochrome P450s and alcohol dehydrogenase in biotransformation.
Diao X; Deng P; Xie C; Li X; Zhong D; Zhang Y; Chen X
Drug Metab Dispos; 2013 Feb; 41(2):430-44. PubMed ID: 23169608
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantitation of 3-n-butylphthalide (NBP) and its four major metabolites in human plasma by LC-MS/MS using deuterated internal standards.
Diao X; Ma Z; Wang H; Zhong D; Zhang Y; Jin J; Fan Y; Chen X
J Pharm Biomed Anal; 2013 May; 78-79():19-26. PubMed ID: 23434525
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
4. Bioactivation of 3-n-butylphthalide via sulfation of its major metabolite 3-hydroxy-NBP: mediated mainly by sulfotransferase 1A1.
Diao X; Pang X; Xie C; Guo Z; Zhong D; Chen X
Drug Metab Dispos; 2014 Apr; 42(4):774-81. PubMed ID: 24468743
[TBL] [Abstract][Full Text] [Related]
5. In vitro studies on the oxidative metabolism of 20(s)-ginsenoside Rh2 in human, monkey, dog, rat, and mouse liver microsomes, and human liver s9.
Li L; Chen X; Zhou J; Zhong D
Drug Metab Dispos; 2012 Oct; 40(10):2041-53. PubMed ID: 22829543
[TBL] [Abstract][Full Text] [Related]
6. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes.
Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK
Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915
[TBL] [Abstract][Full Text] [Related]
7. Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
Chang Y; Moody DE; McCance-Katz EF
Drug Metab Dispos; 2006 Mar; 34(3):440-8. PubMed ID: 16381669
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and pharmacokinetics of allitinib in cancer patients: the roles of cytochrome P450s and epoxide hydrolase in its biotransformation.
Lin L; Xie C; Gao Z; Chen X; Zhong D
Drug Metab Dispos; 2014 May; 42(5):872-84. PubMed ID: 24598282
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the metabolism of sibiricaxanthone F and its aglycone in vitro by high performance liquid chromatography coupled with Q-trap mass spectrometry.
Song Y; Yang X; Jiang Y; Tu P
J Pharm Biomed Anal; 2012 Nov; 70():700-7. PubMed ID: 22819207
[TBL] [Abstract][Full Text] [Related]
10. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
[TBL] [Abstract][Full Text] [Related]
11. Absorption, distribution, metabolism, and excretion of [
Tian J; Lei P; He Y; Zhang N; Ge X; Luo L; Yan S; Diao X
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Sep; 1181():122915. PubMed ID: 34500404
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective hydroxylation by CYP2C19 and oxidation by ADH4 in the in vitro metabolism of tivantinib.
Nishiya Y; Nakai D; Urasaki Y; Takakusa H; Ohsuki S; Iwano Y; Yasukochi T; Takayama T; Bazyo S; Oza C; Kurihara A; Savage RE; Izumi T
Xenobiotica; 2016 Nov; 46(11):967-76. PubMed ID: 26899628
[TBL] [Abstract][Full Text] [Related]
14. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
[TBL] [Abstract][Full Text] [Related]
15. Stereo- and regioselectivity account for the diversity of dehydroepiandrosterone (DHEA) metabolites produced by liver microsomal cytochromes P450.
Miller KK; Cai J; Ripp SL; Pierce WM; Rushmore TH; Prough RA
Drug Metab Dispos; 2004 Mar; 32(3):305-13. PubMed ID: 14977864
[TBL] [Abstract][Full Text] [Related]
16. Metabolism, excretion, and pharmacokinetics of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid, an EP2 receptor-selective prostaglandin E2 agonist, in male and female Sprague-Dawley rats.
Johnson KA; Prakash C
Drug Metab Dispos; 2005 Aug; 33(8):1191-201. PubMed ID: 15886349
[TBL] [Abstract][Full Text] [Related]
17. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac.
Tang W; Stearns RA; Wang RW; Chiu SH; Baillie TA
Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798
[TBL] [Abstract][Full Text] [Related]
18. In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism.
Yu J; Brown DG; Burdette D
Drug Metab Dispos; 2010 Oct; 38(10):1767-78. PubMed ID: 20595377
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics in Sprague-Dawley rats and Beagle dogs and in vitro metabolism of ZJM-289, a novel nitric dioxide donor.
Li N; Qiu Z; Wang X; Li T; Ji H; Zhang Y; Lu Y; Zhao D; Chen X
Xenobiotica; 2014 Jan; 44(1):59-69. PubMed ID: 23773000
[TBL] [Abstract][Full Text] [Related]
20. Identification of human cytochrome P450 isozymes responsible for the in vitro oxidative metabolism of finasteride.
Huskey SW; Dean DC; Miller RR; Rasmusson GH; Chiu SH
Drug Metab Dispos; 1995 Oct; 23(10):1126-35. PubMed ID: 8654202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
